218 related articles for article (PubMed ID: 767057)
1. Humoral factors abrogating cell-mediated immunity in the tumor-bearing host.
Baldwin RW; Robins RA
Curr Top Microbiol Immunol; 1975; 72():21-53. PubMed ID: 767057
[No Abstract] [Full Text] [Related]
2. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
Baldwin RW; Embleton MJ; Robins RA
Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609
[No Abstract] [Full Text] [Related]
3. Cellular and humoral immune interactions during neoplastic development.
Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
[No Abstract] [Full Text] [Related]
4. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
5. Cell-mediated immunity to tumor cells.
Herberman RB
Adv Cancer Res; 1974; 19(0):207-63. PubMed ID: 4604193
[No Abstract] [Full Text] [Related]
6. T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.
Wagner H; Röllinghoff M; Nossal GJ
Transplant Rev; 1973; 17(0):3-36. PubMed ID: 4151904
[No Abstract] [Full Text] [Related]
7. Cell-mediated immune reactions to tumor antigens with particular emphasis on immunity to human neoplasms.
Hellström I; Hellström KE
Cancer; 1974 Oct; 34(4 Suppl):suppl:1461-8. PubMed ID: 4417442
[No Abstract] [Full Text] [Related]
8. Tumor antigens and tumor-host relationships.
Baldwin RW; Price MR
Annu Rev Med; 1976; 27():151-63. PubMed ID: 779594
[No Abstract] [Full Text] [Related]
9. Lymphocyte-mediated immune responses in neoplasia.
Pilch YH; Golub SH
Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
[No Abstract] [Full Text] [Related]
10. Blocking and unblocking serum factors in neoplasia.
Bansal SC; Bansal BR; Boland JP
Curr Top Microbiol Immunol; 1976; 75():45-76. PubMed ID: 797533
[No Abstract] [Full Text] [Related]
11. Immunity in the tumor-bearing host and its modification by serum factors.
Baldwin RW; Embleton MJ; Price MR; Robins A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1452-60. PubMed ID: 4422494
[No Abstract] [Full Text] [Related]
12. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
13. Horizons in tumor immunology. A seminar.
Wilson RE; Alexander P; Rosenberg SA; Simmons RL
Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
[No Abstract] [Full Text] [Related]
14. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
15. Factors interfering with immunological rejection of tumours.
Baldwin RW; Robins RA
Br Med Bull; 1976 May; 32(2):118-23. PubMed ID: 782631
[No Abstract] [Full Text] [Related]
16. In vitro testing in tumor immunotherapy.
Berkelhammer J
Semin Oncol; 1974 Dec; 1(4):397-408. PubMed ID: 4143489
[No Abstract] [Full Text] [Related]
17. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
18. The role of immunology in the diagnosis and treatment of cancer.
Humphrey LJ; Pierce GE
Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
[No Abstract] [Full Text] [Related]
19. Nutrition and tumor immunity: divergent effects of antitumor antibody.
Bull DM
Cancer Res; 1975 Nov; 35(11 Pt. 2):3317-9. PubMed ID: 1104143
[TBL] [Abstract][Full Text] [Related]
20. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
Haba S; Kitagawa M
Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
